Literature DB >> 16807249

CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase.

Liping Qiao1, Ormond A MacDougald, Jianhua Shao.   

Abstract

Excessive hepatic gluconeogenesis and glucose production are important contributors to hyperglycemia in both type 1 and type 2 diabetes. In diabetic humans and animal models, elevated levels of p38 mitogen-activated protein kinase (p38) are observed in several tissues. Our study shows that activity of p38 is significantly elevated in livers of db/db or streptozocin-induced type 1 diabetic mice. Using cultured hepatoma cells, we find that activation of p38 enhances expression of hepatic gluconeogenic gene phosphoenolpyruvate carboxykinase (PEPCK). Furthermore, our studies demonstrate that activation of p38 stimulates phosphorylation of CCAAT/enhancer-binding protein alpha (C/EBPalpha) at serine 21 and increases its transactivation activity in the context of PEPCK gene transcription. Our results indicate that C/EBPalpha mediates p38-stimulated PEPCK transcription in liver cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807249     DOI: 10.1074/jbc.M603038200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  p38α controls erythroblast enucleation and Rb signaling in stress erythropoiesis.

Authors:  Simon M Schultze; Andreas Mairhofer; Dan Li; Jin Cen; Hartmut Beug; Erwin F Wagner; Lijian Hui
Journal:  Cell Res       Date:  2011-09-27       Impact factor: 25.617

2.  Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.

Authors:  Dan Wei; Rongya Tao; Yao Zhang; Morris F White; X Charlie Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-16       Impact factor: 4.310

Review 3.  MAPK signalling in cellular metabolism: stress or wellness?

Authors:  Helmuth Gehart; Susann Kumpf; Arne Ittner; Romeo Ricci
Journal:  EMBO Rep       Date:  2010-10-08       Impact factor: 8.807

4.  Regulation of hepatic six transmembrane epithelial antigen of prostate 4 (STEAP4) expression by STAT3 and CCAAT/enhancer-binding protein alpha.

Authors:  Preeti Ramadoss; Franck Chiappini; Martin Bilban; Anthony N Hollenberg
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

5.  p38 Mitogen-activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene.

Authors:  Kosuke Saito; Rick Moore; Masahiko Negishi
Journal:  Drug Metab Dispos       Date:  2013-03-28       Impact factor: 3.922

6.  Activation of TR4 orphan nuclear receptor gene promoter by cAMP/PKA and C/EBP signaling.

Authors:  Ning-Chun Liu; Wen-Jye Lin; I-Chen Yu; Hung-Yun Lin; Su Liu; Yi-Fen Lee; Chawnshang Chang
Journal:  Endocrine       Date:  2009-07-18       Impact factor: 3.633

7.  Phosphorylation of CCAAT/enhancer-binding protein alpha regulates GLUT4 expression and glucose transport in adipocytes.

Authors:  Hyuk C Cha; Nikhil R Oak; Sona Kang; Tuan-Ahn Tran; Susumu Kobayashi; Shian-Huey Chiang; Daniel G Tenen; Ormond A MacDougald
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

8.  Modulation of fatty acid synthase degradation by concerted action of p38 MAP kinase, E3 ligase COP1, and SH2-tyrosine phosphatase Shp2.

Authors:  Jianxiu Yu; Rong Deng; Helen H Zhu; Sharon S Zhang; Changhong Zhu; Marc Montminy; Roger Davis; Gen-Sheng Feng
Journal:  J Biol Chem       Date:  2012-12-26       Impact factor: 5.157

Review 9.  Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.

Authors:  Amy K Rines; Kfir Sharabi; Clint D J Tavares; Pere Puigserver
Journal:  Nat Rev Drug Discov       Date:  2016-08-12       Impact factor: 84.694

10.  Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.

Authors:  Hanna S Radomska; Meritxell Alberich-Jordà; Britta Will; David Gonzalez; Ruud Delwel; Daniel G Tenen
Journal:  J Clin Invest       Date:  2012-07-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.